À propos de ce podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
211 épisodes · Geneeskunde
On The Pen GLP-1 News
À propos de ce podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Épisodes récents
- They TRIPLED Wegovy Dose, Does it Beat Zepbound?1 oct. · 31 min
- Retatrutide in Court, Compound GLP-1 Under Fire22 sept. · 30 min
- 17% Weight Loss in 16 Weeks… Is This Better Than Retatrutide?15 sept. · 30 min
- GLP-1 for 6 Year Olds? Here’s What the Trial Actually Found8 sept. · 26 min
- We’re Solving Obesity. Now Who Pays for It?2 sept. · 25 min
- GLP-1 Coverage Is COLLAPSING in 202726 août · 35 min
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18 août · 45 min
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12 août · 31 min
- Eli Lilly Earnings Call Recap: Retatrutide News7 août · 1 h 00 min
- Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.4 août · 19 min
podlinkr.com/fr/on-the-pen-glp-1-news
Pour une affiche ou une diapo.